The Effects of TECAR Therapy in the Treatment of Patients With Myofascial Trigger Points in the Upper Trapezius Muscle: A Randomized Controlled Trial
Musculoskeletal Care · 2026-06 · 24 (2)
DOI: 10.1002/msc.70203 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Musculoskeletal Care, online erschienen am 19.04.2026. Verfasst von Hojjat Radinmehr und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiotherapy, School of Rehabilitation Sciences, Hamadan University of Medical Sciences, Hamadan, Iran. Hauptthemen laut MEDLINE: Myofascial Pain Syndromes, Superficial Back Muscles, Trigger Points, Physical Therapy Modalities. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences.
Abstract (Originalsprache)
Objectives
Myofascial pain syndrome affecting the upper trapezius significantly impairs function, and conventional physiotherapy often has limited efficacy in refractory cases. TECAR therapy has emerged as a potential adjunct treatment, though robust evidence supporting its use remains scarce. This study aimed to evaluate the effects of TECAR therapy on pain reduction, neck range of motion, and Neck Disability Index scores in patients with upper trapezius myofascial trigger points.
Methods
This double‐blind, randomized controlled trial enrolled 44 participants with active upper trapezius trigger points. Participants were randomly assigned to one of two groups: standard physiotherapy alone or physiotherapy combined with TECAR therapy. Primary outcomes—assessed before and after the intervention—included pain intensity (measured by VAS), cervical lateral flexion range of motion, and functional disability (evaluated using the NDI).
Results
The TECAR therapy group showed significantly better outcomes across all measured parameters compared to the control group: greater pain reduction (mean VAS difference: −3.77 vs. −2.33), greater improvement in cervical lateral flexion (+7.50° vs. +4.47°), and more substantial functional recovery (NDI change: −14.90 vs. −6.40). These between‐group differences remained statistically significant after adjusting for baseline severity ( p < 0.05 for all comparisons).
Conclusion
TECAR therapy demonstrates clinically meaningful enhancement of conventional physiotherapy outcomes in upper trapezius myofascial pain, particularly among patients with greater baseline disability. Its noninvasive profile and synergistic treatment effects justify its consideration for integration into standard rehabilitation protocols. However, further research with extended follow‐up periods is needed to evaluate its long‐term efficacy. Trial Registration Trial Registration Number: IRCT20190202042581N4, Date of trial registration: 2/11/2022
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiotherapy, School of Rehabilitation Sciences, Hamadan University of Medical Sciences, Hamadan, Iran.
- Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.
Förderung
- Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences
Zitieren
APA
Radinmehr, H., Rahbar, S., Talimkhani, A., Owliaee, P., Montazerlotf, H., & Asadi, M. R. (2026). The Effects of TECAR Therapy in the Treatment of Patients With Myofascial Trigger Points in the Upper Trapezius Muscle: A Randomized Controlled Trial. Musculoskeletal Care, 24(2). https://doi.org/10.1002/msc.70203
Vancouver
Radinmehr H, Rahbar S, Talimkhani A, Owliaee P, Montazerlotf H, Asadi MR. The Effects of TECAR Therapy in the Treatment of Patients With Myofascial Trigger Points in the Upper Trapezius Muscle: A Randomized Controlled Trial. Musculoskeletal Care. 2026;24(2). doi:10.1002/msc.70203
BibTeX
@article{Radinmehr2026,
author = {Radinmehr, Hojjat and Rahbar, Soulmaz and Talimkhani, Ailin and Owliaee, Parsa and Montazerlotf, Hanieh and Asadi, Mohammad Reza},
title = {The Effects of TECAR Therapy in the Treatment of Patients With Myofascial Trigger Points in the Upper Trapezius Muscle: A Randomized Controlled Trial},
journal = {Musculoskeletal Care},
year = {2026},
volume = {24},
number = {2},
doi = {10.1002/msc.70203}
}
EUVIMED